Leadership Overview
AngioDynamics has 6 executives leading key functions including strategy, finance, human resources, legal, and operations.
Driven by a commitment to innovation, AngioDynamics focuses on developing high-quality medical devices that improve patient outcomes, maintaining a strong global presence and contributing to advancements in key healthcare markets worldwide.
Driven by a commitment to innovation, AngioDynamics focuses on developing high-quality medical devices that improve patient outcomes, maintaining a strong global presence and contributing to advancements in key healthcare markets worldwide.
Leadership Roles at AngioDynamics
Yoel Zabar - Chief Executive Officer
Yoel Zabar, the Chief Executive Officer at AngioDynamics, directs the companys overall strategy and operational execution. Zabar guides AngioDynamics in its mission to develop and deliver innovative medical devices that enhance patient care. This leadership role involves setting the strategic vision for global operations and ensuring alignment with market demands. Overseeing all major business functions, Zabar drives the companys growth initiatives and commitment to being a trusted partner within the medical community. The Chief Executive Officer ensures that the companys focus on quality and patient outcomes remains paramount across all divisions. Yoel Zabar is responsible for fostering a culture of continuous improvement and innovation, essential for maintaining AngioDynamics' strong presence in key healthcare markets worldwide.
Robert Palladino - Chief Financial Officer
Robert Palladino, the Chief Financial Officer at AngioDynamics, manages the companys financial planning, reporting, and fiscal strategy. Palladino oversees all aspects of financial operations, ensuring robust fiscal health and supporting the companys growth objectives. This critical role involves managing capital allocation, investor relations, and financial risk mitigation. The Chief Financial Officer works closely with other executive leaders to align financial strategies with the companys mission of improving patient outcomes through innovative medical devices. Robert Palladino ensures compliance with financial regulations and drives efficiency across all financial departments. This leadership position is vital for sustaining AngioDynamics' global operations and its commitment to advancing medical solutions.
Stephen Trowbridge - Executive Vice President & Chief Financial Officer
Stephen Trowbridge, the Executive Vice President & Chief Financial Officer at AngioDynamics, provides strategic financial leadership and oversees critical financial operations. Trowbridge supports the companys mission by ensuring sound financial management and driving fiscal discipline across the organization. This executive role involves close collaboration with the Chief Executive Officer and other senior leaders to shape financial policy and resource allocation. The Executive Vice President & Chief Financial Officer plays a key part in managing the companys financial performance and supporting its global expansion efforts. Stephen Trowbridge is instrumental in maintaining AngioDynamics' financial stability and its capacity to invest in the development of high-quality medical devices. This position ensures the company's financial strategies directly contribute to improved patient outcomes worldwide.
Sibabalo Sibabalo - Group Chief Financial Officer
Sibabalo Sibabalo, the Group Chief Financial Officer at AngioDynamics, directs the financial strategy and oversight for the companys global operations. Sibabalo ensures the financial integrity and performance of the organization, supporting its mission to deliver innovative medical devices. This executive position involves managing complex financial structures and driving fiscal responsibility across all business units. The Group Chief Financial Officer collaborates with senior leadership to optimize resource allocation and support strategic growth initiatives. Sibabalo Sibabalo is critical in maintaining AngioDynamics' financial health and its capacity to invest in research and development. This role ensures that financial planning directly supports the companys commitment to improving patient outcomes on a worldwide scale.
Marna Bronfen-Moore - Senior Vice President, Chief Human Resources Officer
Marna Bronfen-Moore, the Senior Vice President, Chief Human Resources Officer at AngioDynamics, leads all human capital strategies and organizational development initiatives. Bronfen-Moore cultivates a dynamic work environment that supports the companys commitment to innovation and patient care. This role is central to attracting, developing, and retaining top talent essential for AngioDynamics' continued growth and success in the medical device sector. The Senior Vice President, Chief Human Resources Officer ensures that HR policies align with the companys mission and values, fostering a culture of excellence. Marna Bronfen-Moore oversees employee relations, talent management, and compensation and benefits programs, directly impacting the operational effectiveness of AngioDynamics' global workforce. This leadership ensures the company's human resources are optimized to drive advancements in medical solutions.
Larry Weiss - Chief Legal Officer & Corporate Secretary
Larry Weiss, the Chief Legal Officer & Corporate Secretary at AngioDynamics, provides comprehensive legal counsel and oversees corporate governance. Weiss ensures the company operates in full compliance with all applicable laws and regulations, safeguarding AngioDynamics' interests. This pivotal role involves managing all legal affairs, including litigation, intellectual property, and regulatory matters pertinent to the medical device industry. The Chief Legal Officer & Corporate Secretary works closely with the Board of Directors and executive team to uphold the highest standards of corporate integrity. Larry Weiss is essential in navigating the complex legal landscape, supporting the companys mission to develop high-quality medical devices and maintain its global presence. This leadership ensures legal frameworks align with strategic objectives for patient outcome improvement.
Explore Leadership Teams in Manufacturing
Founded in Japan in 1951 and headquartered in Tokyo, Japan, Nihon Kohden is a manufacturer, developer, and distributor of medical electronic equipment.
Company Leadership KY
RS
HD
AS
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
EM
BM
Applied Medical, founded in 1987 and headquartered in Rancho Santa Margarita, California, is a company that specializes in medical devices.
Company Leadership ZF
GJ
SW
FUJIFILM Healthcare Americas Corporation is a medical manufacturing company providing diagnostic and enterprise imaging solutions designed to meet the evolving needs of healthcare across prevention, diagnosis, and treatment. FUJIFILM Healthcare Americas Corporation is based in Lexington, Massachusetts.
Company Leadership
HS
RH
Frequently Asked Questions Regarding AngioDynamics Top Executives and Leadership Team
